TWiV reviews results of a phase 3 trial of a self-amplifying mRNA COVID-19 vaccine, and the finding that baseline innate and T cell populations are correlates of protection against symptomatic influenza virus infection independent of serology.
Hosts: Dickson Despommier, Alan Dove and Brianne Barker
Click arrow to play
Download TWiV 1115 (72 MB .mp3, 100 min)
Subscribe (free): Apple Podcasts, Google Podcasts, RSS, email
Become a patron of TWiV!
Links for this episode
- MicrobeTV Discord Server
- MicrobeTV store at Cafepress
- Michelson Prizes: Next Generation Grants 1:35
- Immunogenicity and safety of self-amplifying mRNA COVID-19 vaccine (Lancet Inf Dis) 5:36
- First self-amplifying mRNA vaccine approved in Japan (Science)
- Rise of the RNA machines (Trends Biochem)
- Innate and T cell populations correlates of protection against influenza (Nat Immunol) 23:34
- Timestamps by Jolene. Thanks!
Weekly Picks 1:24:34
Dickson – Nitrogen-fixing organelle in a marine alga
Brianne – Mapping a lost branch of the Nile
Alan – Interactive version of the updated USDA gardening zone map on NPR.
Intro music is by Ronald Jenkees
Send your virology questions and comments to twiv@microbe.tv
Leave a Reply